Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys, Oxford Nanopore Partner on Software Development for Single-molecule NGS Platform

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Accelrys today announced a collaboration with Oxford Nanopore Technologies to develop software for the analysis of complex, real-time data generated by Oxford Nanopore's single-molecule DNA sequencing platform.

Nanopore-specific data analysis pipelines for Accelrys' Pipeline Pilot will be offered as the preferred and supported software for secondary and higher level data analysis for Oxford's Nanopore sequencing system upon its commercialization, Accelrys said. One of those pipelines is Accelrys' new NGS Collection for Pipeline Pilot software, which the San Diego-based company said is compatible with all leading sequencing technologies.

Financial and other terms of the deal were not disclosed.

While the collaboration is initially focused on DNA sequencing, in the future it could include development into other applications, such as protein analysis, Accelrys noted.

"In our nanopore technology development, we focus on the need to improve overall workflows that deliver experimental results to the end user, not just the molecular analysis part of an experiment," Clive Brown, chief technology officer for Oxford Nanopre, said in a statement. "The Accelrys Pipeline Pilot software is uniquely placed to deliver nanopore-specific workflow features, such as real-time experimental analysis, in an accessible and versatile way appropriate for a broad range of users from individual researcher to large scale installations."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.